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Activin A, a member of the TGFb-superfamily, is well
known to play important roles in the growth and
differentiation of various target cells. We have pre-
viously demonstrated that activin A is produced at an
early stage of cultivation at both the protein and the
mRNA levels in cultured human keratinocytes. In this
study, the effects of activin A on differentiation and
proliferation of human keratinocytes were examined.
Activin A (^1 nM) induced cornified envelope forma-
tion and the synthesis of loricrin, keratin 1, involucrin,
and transglutaminase 1. In addition, transglutaminase
Activin A, a member of the TGFβ-superfamily thatwas originally purified from ovarian fluids, stimulatessecretion of follicle-stimulating hormone from theanterior pituitary gland (Ling et al, 1986; Vale et al,1986). Erythroid differentiation factor was independ-
ently isolated from human monocytic leukemia cells (Eto et al,
1987). Molecular cloning of cDNA has shown that activin A and
erythroid differentiation factor are identical. Activins have been
identified as homo- or heterodimers of the βA and βB chain and
have been classified into three types: activin A (βAβA), activin B
(βBβB), and activin AB (βAβB). Activins induce differentiation of
hematopoietic cells (Eto et al, 1987), osteoblasts (Ogawa et al,
1992), and endocrine cells (Sugino et al, 1988), and inhibit
proliferation of gonadal cell lines (Gonzalez-Manchon and Vale,
1989), hepatocytes (Yasuda et al, 1993), and endothelial cells
(McCarthy and Bicknell, 1993). We have previously shown that
mRNA of activin A (βA), but not βB, is detected in normal human
epidermis and in keratinocytes at an early culture stage (Seishima
et al, 1996). In contrast to our results, Roberts et al showed that
activin βA is expressed in the developing hair bulb and also in the
dermal layer of embryonic skin, but not in adult skin (Roberts
et al, 1991). It has been reported that activin A expression is
enhanced in keratinocytes by cutaneous injury (Hu¨bner et al, 1996)
and by the addition of interleukin 1β, tumor necrosis factor α, or
serum (Hu¨bner and Werner, 1996). On the other hand, mice
lacking the activin βA-chain in whiskers and whisker follicles are
abnormal (Matzuk et al, 1995a). Furthermore, mice deficient in
follistatin, an activin binding protein, show disturbed whisker
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activity and mRNA level of transglutaminase 1 were
increased by activin A. [3H]Thymidine incorporation
and cell number were reduced by activin A (^1 nM)
compared with control, suggesting an inhibitory effect
of activin A on cell proliferation. On the basis of these
findings, it is likely that activin A contributes to
differentiation and suppression of proliferation in
human keratinocytes. Key words: loricrin/proliferation/
transforming growth factor b-superfamily/transglutaminase
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development and hyperkeratotic skin (Matzuk et al, 1995b). These
findings suggest that activin A plays an important role in keratinocyte
functions; however, the role of activins in keratinocytes has not
been fully determined. The aim of this study was to investigate the
effects of activin A on proliferation and differentiation in cultured
human keratinocytes.
MATERIALS AND METHODS
Cell culture and cell number count Normal human keratinocytes
from foreskin (Kurabo, Osaka, Japan) were grown in Eagle’s minimum
essential medium (with 0.09 mM Ca2) supplemented with antibiotics (100
units penicillin per ml, 100 mg streptomycin per ml) and 10% fetal calf
serum (HyClone Laboratories, Logan, UT) on 60 mm dishes (Corning
Plastics) at 37°C with 5% CO2/95% air in a humidified incubator. To
adjust the Ca21 level in the medium to 0.09 mM, fetal calf serum treated
with 8% Chelex 100 (Bio-Rad Laboratories, Richmond, CA) and 0.09 mM
Ca2 were added to Ca21 and Mg21 free-minimum essential medium
(Whittaker Bioproducts, Walkerville, MD) (Li et al, 1996). Cells were used
after one passage and the medium was changed every 2–3 d. After reaching
confluence, the cells were treated with Hank’s balanced salt solution
containing 0.02% trypsin and 0.02% ethylenediamine tetraacetic acid for
15 min at 37°C, and were then resuspended in the culture medium. The
cells were seeded onto 35 mm dishes at a density of 13105 per ml of
culture medium in the presence of 0.09 mM (low) or 1.8 mM (normal
concentration) of calcium. After incubation with activin A at different
concentrations (0, 0.1, 1, 10, or 100 nM) for 24 h, the cells were washed
with phosphate-buffered saline (PBS) and were dissociated by treatment
with 0.25% trypsin and 0.1% ethylenediamine tetraacetic acid solution at
37°C for 10 min. After centrifugation at 1000 3 g for 10 min, the cells
were resuspended in 10 mM Tris-HCl buffer, pH 7.5 and then the cell
number was counted under a microscope. Subconfluent and monolayer
culture was observed after 36 h incubation without activin A.
Measurement of DNA synthesis DNA synthesis was assessed by
measuring the incorporation of [3H]thymidine. After keratinocytes were
cultured with activin A at different concentrations for 24 h, the cells were
labeled with 1.0 µCi [3H]thymidine per ml for 4 h. Cultures were washed
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three times with PBS and then lyzed with 2N NaOH at 37°C for 20 min
and neutralized with 2N HCl. Acid-insoluble material was precipitated by
addition of four volumes of ice-cold trichloroacetic acid and was collected
on GF/A glass-fiber filters (Whatman, Ann Arbor, MI). After washing
three times with 10% trichloroacetic acid and once with ethanol, the filters
were dried at room temperature for measurement of radioactivity with a
liquid scintillation counter (Beckman LS 7500).
Transglutaminase activity assay Tranglutaminase (TGase) activity was
assayed by measuring the formation of ε-amino-γ-glutamyl bonds between
[3H]putrescine and casein (Yuspa et al, 1980; Seishima et al, 1993). After
incubation with 0.1, 1, 10, or 100 nM of activin A for 24 h, cells were
scraped off and sonicated in 10 mM Tris HCl buffer (pH 7.4) containing
10 mM dithreitol, 0.5 mM ethylenediamine tetraacetic acid, and 0.1%
Triton X-100. The homogenates were centrifuged at 105,000 3 g for
60 min and the resultant supernatants were used for the TGase activity
assay. One hundred microliters of cell lysate was incubated with 100 liters
of 50 mM Tris-HCl buffer (pH 7.4) containing casein (20 g per ml) and
[3H]putrescine (5 mM). After incubation for 30 min at 37°C, the reactions
were terminated by adding the same volume of ice-cold 10% trichloroacetic
acid and the mixture was kept on ice for 30 min. The acid-insoluble
material was collected on GF/A glass-fiber filters. After three washes with
5 ml of 5% ice-cold trichloroacetic acid containing 1% putrescine, the
filters were dried at room temperature. The dried filters were mixed with
scintillation fluid and the radioactivity was determined with a liquid
scintillation counter.
Scoring of cornified envelopes The scoring of cornified envelope
formation was performed essentially as described by Sun and Green (1976).
The cells incubated with activin A at various concentrations for 24 h were
washed with PBS, and were dissociated by treatment with 0.25% trypsin
and 0.1% ethylenediamine tetraacetic acid solution at 37°C for 10 min.
After centrifugation at 1000 3 g for 10 min, the cells were resuspended
in 10 mM Tris-HCl buffer, pH 7.5, containing 1% sodium dodecyl sulfate
and 1% 2-mercaptoethanol at a density of 1–2 3 106 cells per ml. After
the cell suspensions had been kept at room temperature for 10 min, sodium
dodecyl sulfate- and mercaptoethanol-resistant cornified envelopes were
counted under a microscope.
Western blot analysis Normal keratinocytes were seeded on 60 mm
dishes at a density of 1 3 105 cells per 5 ml of culture medium in the
presence of 0.09 mM or 1.8 mM calcium. Because TGase activity
and cornified envelope formation were increased by activin A at the
concentration of 1 nM or more and TGase activity in human keratinocytes
is mostly due to TGase 1 (Kim et al, 1995a), 1 nM of activin A was used
in this study to examine the effects of activin A on the synthesis of TGase
1, loricrin, keratin 1, and involucrin. Cells incubated with activin A for
24 h were washed twice with PBS, and harvested by PBS with 1 mM
phenylmethylsulfonyl fluoride (Molecular Probes, Eugene, OR), 1 mM
N-tosyl-L-phenylalanine chloromethyl ketone (TPCK, Research Organics,
Cleveland, OH), and 5 mM E64 (Enzyme System Products, Dublin, CA).
We performed western blot analysis using monoclonal antibodies against
human TGase 1 (Kim et al, 1995b), loricrin (Yoneda and Steinert, 1993),
keratin 1 (34βB4, Enzo Diagnotics, Farmingdale, NY), and rabbit polyclonal
antibody to involucrin (BT601, Biomedical Technologies, Stoughton,
MA). Aliquots were mixed with sample buffer (10% 2-β-mercaptoethanol,
2% sodium dodecyl sulfate, 30% glycerol, 0.25 M Tris, final concentration),
followed by heating at 98°C for 3 min. Thirty micrograms of protein was
loaded per lane and reducing sodium dodecyl sulfate-polyacrylamide gel
electrophoresis was performed with 10% polyacrylamide gel for TGase 1,
20% gel for loricrin, and 8% gel for involucrin and keratin 1 by the method
of Laemmli (1970). Protein standards for molecular weight (Bio Rad) were
as follows: ovalbumin, 49 kDa; bovine serum albumin, 80 kDa; β-
galactosidase, 116.5 kDa; and myosin, 205 kDa. Proteins were electroblotted
onto Hybond-ECL (Amersham, Bucks, U.K.) using a semi-dry transfer
apparatus (Bio Rad) for 30 min at 10 V. The membranes were preincubated
with a blocking solution containing 5% skim milk and 0.2% Tween 20 in
PBS for 1 h at room temperature. Membranes were then incubated
overnight at 4°C with diluted primary antibodies. Following incubation
with horseradish peroxidase-conjugated anti-mouse IgG or anti-rabbit IgG
(0.2 µl per ml) in the blocking solution for 2 h, membranes were washed
and bound antibodies were detected by using ECL detection reagents
(Amersham) and exposure to Hyperfilm.
Northern blot analysis After keratinocytes were incubated without or
with 1 nM of activin A for 12 h, total RNA was extracted from the cells
with a buffered solution containing 4 M guanidium thiocyanate according
Figure 1. Suppression of keratinocyte proliferation by activin A.
Dose-dependent effects of activin A on cell number (A, B) and
[3H]thymidine incorporation (C, D) in low (A, C) or normal calcium (B,
D) media are shown. After incubation with activin A at 1–100 nM for
24 h, the number of keratinocytes was markedly decreased compared
with control under both low (A) and normal (B) calcium conditions.
[3H]Thymidine incorporation was significantly reduced by exposure for
24 h to 1, 10, or 100 nM of activin A in both low (C) and normal (D)
calcium conditions. Values are means of triplicate determinations from
three separate experiments. Error bars: 1 SD. *p , 0.05, **p , 0.005,
***p , 0.001.
to the method of Chomzynski and Sacchi (1987). The TGase 1 cDNA
was labeled with α-32P-dCTP using a multiprime DNA labeling system,
and hybridization was performed at 37°C for 15 h. After hybridization,
the filters were washed and subjected to autoradiography.
Data analysis Data are expressed as mean 6 1 SD, and statistical
differences were evaluated using Student’s t test. p values less than 0.05
were taken as significant.
RESULTS
Suppression of keratinocyte proliferation by activin A Cell
numbers were counted to evaluate the effect of activin A on
keratinocyte proliferation. Cell numbers as well as [3H]thymidine
incorporation in the low calcium medium were higher than those
in the normal calcium medium when activin A was not added.
After incubation with activin A at 1–100 nM for 24 h, the number
of keratinocytes was markedly decreased compared with control
under both low and normal calcium conditions (Fig 1). Cell
proliferation was decreased with time by 1 nM of activin A for up
to 36 h (Fig 2). Further incubation in the medium without activin
A (for 36 h) after 36 h incubation with 1 nM of activin A did
not induce recovery of cell growth. In addition, [3H]thymidine
incorporation was measured to examine the effect of activin A on
DNA synthesis. DNA synthesis was significantly reduced by activin
A at the concentrations of 1, 10, and 100 nM for 24 h incubation
in either low or normal Ca21 concentration (Fig 1). Moreover,
[3H]thymidine incorporation in cells incubated with 1 nM of
activin A (9.83 6 0.93 3 10–4 cpm per 105 cells, n 5 3) for 24 h
was restored to the basal level by pretreatment with 3 nM of
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Figure 2. Time-dependently reduced keratinocyte proliferation by
activin A until 36 h. Time-dependent effects of activin A (1 nM) on cell
number of human keratinocytes cultured in low calcium media are
shown. Values are means of triplicate determinations from three separate
experiments. Error bars: SD.
follistatin, an activin binding protein, for 6 h under low calcium
conditions (13.1 6 0.98 3 10–4 cpm per 105 cells, n 5 3,
p , 0.001); however, low activin A concentration (0.1, 0.05, and
0.01 nM) did not affect either the cell numbers or the [3H]thymidine
incorporation. Pretreatment with 0.3 nM of follistatin similarly did
not affect cell number and [3H]thymidine incorporation at the low
concentrations of activin A.
Keratinocyte differentiation induced by activin A The
effects of various concentrations of activin A on differentiation were
examined by monitoring cornified envelope formation. Cornified
envelope formation in 1, 10, or 100 nM of activin A-treated cells
was significantly increased compared with control, but no change
was observed in 0.1 nM of activin A (Fig 3). Because TGase 1 is
a key enzyme for keratinocyte differentiation, we examined the
effects of activin A on TGase activity, TGase 1 mRNA level, and
TGase 1 synthesis. TGase activity was increased at 12 h, and
reached a plateau at 36 h (Fig 4), in cells treated or not treated
with activin A (1 nM). TGase activity was significantly increased
by activin A at more than 1 nM compared with control at 24 h,
but no increase was observed in low concentration of activin A
(0.1 nM) (Fig 3). In addition, 1 nM of activin A-induced TGase
activity at 24 h was significanty suppressed to the basal level by
pretreatment with 3 nM of follistatin for 6 h in normal calcium
medium (44.4 6 3.75 vs 21.9 6 3.60 3 10–3 cpm per µg prot.
per 30 min, n 5 3, p , 0.005).
The expression of TGase 1 mRNA and the synthesis of TGase,
loricrin, keratin 1, and involucrin were enhanced in the normal
calcium condition as compared with low calcium (Fig 5). Because
the TGase activity and cornified envelope formation were increased
by activin A at concentrations of 1 nM or more (Fig 3), 1 nM of
activin A was employed to examine the effects of activin A on the
expression of these differentiation markers. The synthesis of TGase
1, loricrin, keratin 1, and involucrin was enhanced by 1 nM of
activin A under both normal and low calcium conditions (Fig 5A,
C–E, respectively). The TGase 1 mRNA level examined by
northern blot analysis was obviously increased by treatment with
1 nM of activin A for 12 h under both normal and low calcium
conditions (Fig 5B).
Figure 3. Keratinocyte differentiation induced by 1–100 nM of
activin A. Dose-dependent effects of activin A on cornified envelope
formation (CE) (A, B) and transglutaminase (TGase) activity (C, D) in low
(A, C) or normal calcium (B, D) media are shown. Cornified envelope
formation and TGase activity were significantly increased by incubation
with activin A at 1 nM or more for 24 h. Values are means of triplicate
determinations from three separate experiments. Error bars: SD. *p , 0.05,
**p , 0.001.
DISCUSSION
In this study, two different calcium conditions, 0.09 mM (low
concentration) and 1.8 mM (normal concentration), were employed
for culture, because it is well known that a low concentration
of calcium induces proliferation, and normal calcium induces
differentiation in keratinocytes (Henning and Holbrook, 1983;
Yuspa et al, 1989). As expected, the cell number and [3H]thymidine
incorporation in the low calcium medium were significantly higher
than those in normal calcium, and the expression of keratinocyte
differentiation markers such as cornified envelope formation and
TGase activity in the low calcium medium were lower than those
in normal calcium, irrespective of the presence of activin A. The
addition of activin A at different concentrations ranging from 1 to
100 nM inhibited the increase in the cell number and [3H]thymidine
incorporation dose-dependently under both calcium conditions,
indicating that activin A inhibits cell proliferation.
Cornified envelope, which is formed beneath the plasma mem-
brane and is resistant to detergents and reducing agents, is character-
istic of the terminal differentiation of keratinocytes. TGase 1, a key
enzyme for keratinocyte differentiation, is a Ca21-requiring enzyme
that catalyses the cross-linking of membrane proteins to form
cornified envelopes. The effect of various concentrations of activin
A on the differentiation of cultured keratinocytes was examined
by monitoring cornified envelope formation and TGase activity.
Both markers were enhanced in a dose-dependent manner. This
enhancement in TGase activity is mostly due to the increase in
TGase 1 activity, because it is now known that the TGase activity
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in human keratinocytes is mostly due to TGase 1 (Kim et al, 1995a).
Although Hohl et al (1991) showed that Ca21 concentrations above
0.1 mM were permissive for the expression of loricrin mRNA,
our data clearly demonstrate that activin A even in low Ca21
contributes to the terminal differentiation of cultured human
keratinocytes. In addition, the expression of TGase 1 mRNA, and
the synthesis of TGase, loricrin, keratin 1, and involucrin were
enhanced with even 1 nM of activin A. These findings suggest
that activin A induces early and terminal differentiation of keratino-
cytes at concentrations of 1 nM or more.
Figure 4. Time-dependent increase in TGase activity by 1 nM of
activin A. TGase activity was increased at 12 h, and reached plateau at
36 h in human keratinocytes cultured in normal calcium media. Values are
means of triplicate determinations from three separate experiments. Error
bars: 1 SD.
Figure 5. Enhanced expression of
TGase 1, loricrin, keratin 1, and
involcrin and increased TGase 1
mRNA level by 1 nM of activin A. The
synthesis of TGase 1 (A), loricrin (C),
keratin 1 (D), and involucrin (E) was
enhanced by the incubation with 1 nM of
activin A for 24 h in both low and normal
calcium conditions. The TGase 1 mRNA
expression (B) was also enhanced by the
incubation with activin A (1 nM) for
12 h. Similar results were obtained in
three independent experiments. Molecular
weight markers (KD) are indicated
in (A) (left). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNA was used
as a control in northern blot analysis (B).
In other cells, activin A inhibits neural differentiation (Hashimoto
et al, 1990) and stimulates glucose production in hepatocytes (Mine
et al, 1989) at 1 nM, modulates osteoblast proliferation and
differentiation at 10 nM (Hashimoto et al, 1992), inhibits the
growth of mammary epithelial cells at 100 nM, and induces
erythroid differentiation at 1 µM. On the other hand, low concen-
tration (0.01 nM) of activin A stimulates the differentiation of
human lung fibroblasts into myofibroblasts and proliferation of
fibroblasts (Ohga et al, 1996). This different responsiveness to
activin A might be due to differences in cell types, quantities, or
binding activities of activin receptors or activin inhibitors. Activin
receptors are transmembrane serine/threonine kinases, among them
type I receptors (ARI and ARIB) and type II receptors (ARII and
ARIIB) (Ca´rcamo et al, 1994; Lebrun and Vale, 1997). Follistatin
is an activin binding protein exerting a neutralizing effect on activin
activity (Nakamura et al, 1990). Mad proteins function downstream
of the activin receptor pathway (Chen et al, 1996).
The endogenous activin A activity in cultured DJM-1 cells, a
squamous cell carcinoma line, corresponded to the activity generated
by 0.32 nM of recombinant activin A. No activin was detected in
normal human keratinocytes (less than 0.02 nM) (Seishima et al,
1996). Activins are reported to be secreted in an autocrine or
paracrine manner (Shiozaki et al, 1992). Therefore, the effect of
activin A was compared with control, which lacked exogenous
activin A.
We have previously demonstrated that activin A mRNA (βA) is
detected at an early stage of keratinocyte culture and that activin
A is observed at the wound edge in an in vitro tissue injury model,
where cell migration and proliferation are activated without terminal
differentiation (Seishima et al, 1996). The induction of activin A
expression was also found in wounded skin, especially granulation
tissue below the eschar, within 7 d of skin injury, suggesting that
activin A plays an important role in tissue repair (Hu¨bner et al,
1996). These observations appear to be in disagreement with our
results. Namely, our previous results suggest that activin A acts as
a potent inducer of proliferation, but this study indicates that activin
A is an inhibitor of proliferation and a stimulator of differentiation.
This apparent discrepancy can be explained as follows: activin A
may upregulate proliferation and stimulate migration at the wound
edge or early stage of cultivation, but it may downregulate
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proliferation and stimulate differentiation at higher concentrations
given exogenously. In other words, activin A might be an initial
modulator of differentiation in keratinocytes.
In conclusion, activin A appears to play a role in the proliferation
and differentiation of cultured human keratinocytes. Further in vivo
studies on the precise regulation mechanisms for proliferation and
differentiation by activin A, including the signaling pathway and
nuclear responses, are needed to elucidate the roles of activin A in
epidermis.
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